2011 Annual Meeting | Neuromuscular Junction Disorders

Date Saturday 04/16/11

Time 09:00 AM - 01:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type AM Half-Day Course

Director(s) Janice M. Massey, MD, FAAN

Topic(s)

Learning Objectives Participants should be familiar with the diagnosis and management of patients with myasthenia gravis and related disorders; learn to critically select therapies; and be able to distinguish myasthenia gravis, MuSk myasthenia and Lambert Eaton syndrome.

CME Available No CME available

Core Competencies Patient Care & Procedural Skills, Professionalism, Medical Knowledge, Practice-based Learning and Improvement

Recommended Audience Trainee, General Neurologist, Specialist Neurologist

Teaching Styles Case-based, Didactic, Audience Participation

Event Timeline
09:00 AM - 09:10 AM		Introduction Janice M. Massey, MD, FAAN
09:10 AM - 09:40 AM		Clinical Features of Acquired Myasthenia Gravis Janice M. Massey, MD, FAAN
09:40 AM - 10:30 AM		Case Studies: Medical Management of MG Julie Rowin, MD, FAAN
10:30 AM - 10:45 AM		Questions and Answers
10:45 AM - 11:00 AM		Break
11:00 AM - 11:50 AM		MuSK Myasthenia Gravis Donald B. Sanders, MD, FAAN
11:50 AM - 12:40 PM		Lambert-Eaton Myasthenic Syndrome Vern C. Juel, MD, FAAN
12:40 PM - 01:00 PM		Questions and Answers

Faculty Disclosures
Janice M. Massey, MD, FAAN	Dr. Massey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenix. Dr. Massey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Revance Therapeutics. Dr. Massey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Momenta. The institution of Dr. Massey has received research support from Revance .
Donald B. Sanders, MD, FAAN	Dr. Sanders has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Accordant Health Services. Dr. Sanders has received personal compensation in the range of $0-$499 for serving as a Consultant for Cabaletta BIO. Dr. Sanders has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kashiv Biosciences. Dr. Sanders has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Momenta Pharmaceuticals. Dr. Sanders has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen RnD. Dr. Sanders has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-aventis. Dr. Sanders has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for VielaBio. Dr. Sanders has received publishing royalties from a publication relating to health care.
Vern C. Juel, MD, FAAN	Dr. Juel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunovant. Dr. Juel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Juel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Accordant Health Services. Dr. Juel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. The institution of Dr. Juel has received research support from argenx. The institution of Dr. Juel has received research support from Alexion. The institution of Dr. Juel has received research support from Janssen. The institution of Dr. Juel has received research support from NIH Rare Diseases Network.
Julie Rowin, MD, FAAN	No disclosure on file

��ɫ��

��ɫ��